Edoc Acquisition Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Kevin Chen

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	3.5yrs
CEO ownership	n/a
Management average tenure	no data
Board average tenure	3.3yrs

Recent management updates

Recent updates

Edoc Acquisition announces termination of deal with Calidi Biotherapeutics

Aug 15

CEO

Kevin Chen (45 yo)

3.5yrs

Tenure

Mr. Kevin Chen has been Chairman of the Board and Chief Executive Officer at Edoc Acquisition Corp. September 2020. Mr. Chen serves as a Director at InFinT Acquisition Corporation since November 23, 2021....

Board Members

Name	Position	Tenure	Compensation	Ownership
Kevin Chen	Chairman of the Board & CEO	3.5yrs	no data	no data
Bob Ai	CFO & Director	3.3yrs	no data	no data
Gang Li	Independent Director	3.3yrs	no data	no data
Yan Li	Independent Director	1.4yrs	no data	no data
Jintao Zheng	Independent Director	1.4yrs	no data	no data

3.3yrs

Average Tenure

50yo

Average Age

Experienced Board: ADOC's board of directors are considered experienced (3.3 years average tenure).

Edoc Acquisition Management

Management criteria checks 1/4

Key information

Recent management updates

High number of new and inexperienced directors

Edoc Acquisition Corp. Appoints Yan Michael Li and Jintao Zheng as Independent Directors

Edoc Acquisition Corp. Announces Board Changes

Recent updates

EDOC Acquisition Files Form 15

Edoc Acquisition Intends to File Form 15

Australian Oilseeds Investments Pty Ltd. completed the acquisition of Edoc Acquisition Corp. (NasdaqCM:ADOC) from American Physicians LLC, Harradan Circle Investors, LP, Mint Tower Capital Management B.V. and others in a reverse merger transaction.

Edoc Acquisition Corp. announced that it has received $0.25 million in funding

Edoc Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Edoc Acquisition Corp. announced that it has received $0.25 million in funding

Edoc Acquisition Receives a Notice from the Staff of the Listing Qualifications Department of the Nasdaq Stock Market

Edoc Acquisition Corp. announced delayed 10-Q filing

Edoc Acquisition Corp. Receives Non-Compliance Letter from Nasdaq

New major risk - Financial position

Edoc Acquisition Corp. announced that it expects to receive $7 million in funding from Australian Oilseeds Investments Pty Ltd.

New major risk - Financial position

Edoc Acquisition Corp. Auditor Raises 'Going Concern' Doubt

Edoc Acquisition Submits A Plan of Compliance to the Nasdaq with Respect to the Annual Meeting Deficiency

Edoc Acquisition Receives Non-Compliance Notice from Nasdaq

High number of new and inexperienced directors

Australian Oilseeds Investments Pty Ltd. entered into a definitive Business Combination Agreement to acquire Edoc Acquisition Corp. (NasdaqCM:ADOC) in a reverse merger transaction.

Edoc Acquisition Corp. Appoints Yan Michael Li and Jintao Zheng as Independent Directors

Edoc Acquisition Corp. Announces Board Changes

Edoc Acquisition announces termination of deal with Calidi Biotherapeutics

EDOC Acquisition Receives A Deficiency Letter from the Listing Qualifications Department of the Nasdaq Stock Market Regarding Market Value of Listed Securities Requirement

Calidi Biotherapeutics, Inc. entered into a definitive agreement to acquire Edoc Acquisition Corp. (NasdaqCM:ADOC) from American Physicians LLC and others for $400 million in a reverse merger transaction.

Edoc Acquisition Corp. (NasdaqCM:ADOC) entered into an agreement to acquire Calidi Biotherapeutics, Inc. from WON & PARTNERS Limited for $400 million.

Edoc Acquisition Corp. Regains Nasdaq Compliance Following Filing of Delayed Annual Report and Quarterly Report

Edoc Acquisition Regains Nasdaq Compliance Following Filing of Delayed Annual Report and Quarterly Report

Edoc Acquisition Corp. announced delayed 10-Q filing

Edoc Acquisition Corp. announced delayed annual 10-K filing

CEO

Tenure

Board Members

Average Tenure

Average Age